BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10506117)

  • 1. N-demethylation accompanies alpha-hydroxylation in the metabolic activation of tamoxifen in rat liver cells.
    Phillips DH; Hewer A; Horton MN; Cole KJ; Carmichael PL; Davis W; Osborne MR
    Carcinogenesis; 1999 Oct; 20(10):2003-9. PubMed ID: 10506117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N, N-didesmethyltamoxifen.
    Brown K; Heydon RT; Jukes R; White IN; Martin EA
    Carcinogenesis; 1999 Oct; 20(10):2011-6. PubMed ID: 10506118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic activation of tamoxifen and alpha-hydroxytamoxifen to DNA-binding species in rat hepatocytes proceeds via sulphation.
    Davis W; Venitt S; Phillips DH
    Carcinogenesis; 1998 May; 19(5):861-6. PubMed ID: 9635875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.
    Gamboa da Costa G; Marques MM; Freeman JP; Beland FA
    Chem Res Toxicol; 2003 Sep; 16(9):1090-8. PubMed ID: 12971796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.
    Gamboa da Costa G; Marques MM; Fu X; Churchwell MI; Wang YP; Doerge DR; Beland FA
    Cancer Lett; 2007 Nov; 257(2):191-8. PubMed ID: 17765393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen.
    Phillips DH; Potter GA; Horton MN; Hewer A; Crofton-Sleigh C; Jarman M; Venitt S
    Carcinogenesis; 1994 Aug; 15(8):1487-92. PubMed ID: 8055624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes.
    Phillips DH; Carmichael PL; Hewer A; Cole KJ; Hardcastle IR; Poon GK; Keogh A; Strain AJ
    Carcinogenesis; 1996 Jan; 17(1):89-94. PubMed ID: 8565142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
    Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
    Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tamoxifen and alpha-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method.
    Martin EA; Heydon RT; Brown K; Brown JE; Lim CK; White IN; Smith LL
    Carcinogenesis; 1998 Jun; 19(6):1061-9. PubMed ID: 9667745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes.
    Phillips DH; Carmichael PL; Hewer A; Cole KJ; Poon GK
    Cancer Res; 1994 Nov; 54(21):5518-22. PubMed ID: 7923188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.
    Jarman M; Poon GK; Rowlands MG; Grimshaw RM; Horton MN; Potter GA; McCague R
    Carcinogenesis; 1995 Apr; 16(4):683-8. PubMed ID: 7728943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
    Boocock DJ; Maggs JL; Brown K; White IN; Park BK
    Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice.
    Umemoto A; Komaki K; Monden Y; Suwa M; Kanno Y; Kitagawa M; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
    Chem Res Toxicol; 2001 Aug; 14(8):1006-13. PubMed ID: 11511174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
    Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells.
    Osborne MR; Davis W; Hewer AJ; Hardcastle IR; Phillips DH
    Chem Res Toxicol; 1999 Feb; 12(2):151-8. PubMed ID: 10027792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction.
    Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH
    Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
    Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
    Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA binding of tamoxifen and its analogues: identification of the tamoxifen-DNA adducts in rat liver.
    Rajaniemi H; Koskinen M; Mäntylä E; Hemminki K
    Toxicol Lett; 1998 Dec; 102-103():453-7. PubMed ID: 10022295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.